Doug Drysdale, Tedor CEO and Terry Novak, COO will be attending the October 9-11 CPhI Worldwide conference to discuss business development and manufacturing opportunities with interested companies. To set up a meeting please email Terry Novak at firstname.lastname@example.org.
TEDOR Pharma announced today the closing of a recapitalization and reorganization of its business, funded by investments from DORA Ventures, Inc.
Tedor Pharma at the 2017 AAPS Annual Meeting and Exposition.
Tedor Pharma is proud to introduce a bold, new brand identity.
A Significant Investment Towards Advancing Tedor Pharma’s Large Scale Commercial Capabilities.
Successful Leader brings Senior Level Operations, Industry Experience. Tedor Pharma, Inc. is announcing the appointment of Roger D. Martin as Chief Operating Officer.
Talented Leader brings Senior Level Operations, Pharmaceutical Sales Experience. Tedor Pharma, Inc. is announcing the appointment of Carl E. Wooten as President and Chief Executive Officer effective February 22, 2016.